Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krupinski, J.
Right arrow Articles by Kaluza, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krupinski, J.
Right arrow Articles by Kaluza, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Stroke. 1997;28:564-573.)
© 1997 American Heart Association, Inc.


Articles

A Putative Role for Platelet-Derived Growth Factor in Angiogenesis and Neuroprotection After Ischemic Stroke in Humans

Jerzy Krupinski, MD, PhD; Razao Issa, MSc; Tomasz Bujny, MD; Mark Slevin, PhD; Pat Kumar, PhD; Shant Kumar, PhD, FRC Pathol; Jozef Kaluza, MD, PhD

From the Department of Biological Sciences, Manchester Metropolitan University (J. Krupinski, R.I., M.S., P.K.); the Department of Clinical Neurosciences, Institute of Psychiatry and King's College School of Medicine and Dentistry, London (J. Krupinski); the Christie Hospital, Manchester (S.K.), UK; and the Department of Neuropathology, Jagiellonian University, Kracow, Poland (J. Krupinski, T.B., J. Kaluza).

Correspondence to Jerzy Krupinski, MD, PhD, Department of Clinical Neurosciences, Institute of Psychiatry and King's College School of Medicine and Dentistry, London SE5 8AF, UK.

Background and Purpose Growth factors control two important processes in infarcted tissue, ie, angiogenesis and gliosis. We recently reported that transforming growth factor-ß1 (TGF-ß1) might be involved in angiogenesis after ischemic stroke in humans; here we present data of an extensive study on platelet-derived growth factor (PDGF) and its receptors.

Methods We studied brain samples from patients who suffered from ischemic stroke for the expression of mRNA encoding PDGF-A, PDGF-B, and PDGF receptors (PDGF-R). Proteins were examined by Western blotting and immunohistochemistry using the antibodies to PDGF-AB, PDGF-BB, PDGF-R{alpha}, and PDGF-Rß.

Results At the mRNA level, PDGF-A and PDGF-B were expressed mainly in neurons in penumbra. PDGF-R mRNA was strongly expressed in some astrocytes but mainly in type III/IV neurons in infarct and penumbra. The least expression was seen in the contralateral hemisphere (P<.001). In contrast, both PDGF-AB and PDGF-BB immunoreactive products were present in most cell types: PDGF-R{alpha} and PDGF-Rß mainly on neurons, and PDGF-Rß on some endothelial cells, with less staining of all the isoforms in the contralateral hemisphere. On Western blots, PDGF-AB and -BB were expressed more within white matter than gray matter of infarct/penumbra, whereas both isoforms of receptor were expressed mainly in gray matter compared with contralateral hemisphere. There was no or very weak expression of the receptor in white matter.

Conclusions PDGF proteins are highly expressed in white matter, suggesting that PDGF may exert its function in white matter participating either in regeneration of damaged axons or in glial scar formation. PDGF-BB and its receptor expressed on microvessel endothelial cells might be involved in angiogenesis after stroke. Thus, PDGF is likely to be angiogenic and neuroprotective in stroke.


Key Words: angiogenesis • cerebral ischemia • growth factors • neuroprotection




This article has been cited by other articles:


Home page
BrainHome page
A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, S. Kumar, P. Kumar, N. Mitsios, and M. Slevin
Changes in hyaluronan production and metabolism following ischaemic stroke in man
Brain, August 1, 2006; 129(8): 2158 - 2176.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. De Marchis, D. Ribatti, C. Giampietri, A. Lentini, D. Faraone, M. Scoccianti, M. C. Capogrossi, and A. Facchiano
Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor
Blood, March 15, 2002; 99(6): 2045 - 2053.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik, and J. Gaffney
Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 in Serum of Patients With Acute Ischemic Stroke
Stroke, August 1, 2000; 31(8): 1863 - 1870.
[Abstract] [Full Text] [PDF]